These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8278326)

  • 1. [Fecal platelet-activating factor (PAF). A marker of digestive inflammatory disorders].
    Denizot Y; Chaussade S; Couturier D
    Presse Med; 1993 Oct; 22(33):1704-6. PubMed ID: 8278326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Presence paf-acether mediator of inflammation in stools of patients with inflammatory enterocolitis].
    Denizot Y; Chaussade S; Colombel JF; Benveniste J; Couturier D
    C R Acad Sci III; 1991; 312(7):329-33. PubMed ID: 1908742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAF-acether and acetylhydrolase in stool of patients with Crohn's disease.
    Denizot Y; Chaussade S; Nathan N; Colombel JF; Bossant MJ; Cherouki N; Benveniste J; Couturier D
    Dig Dis Sci; 1992 Mar; 37(3):432-7. PubMed ID: 1735366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet activating factor in stool from patients with ulcerative colitis and Crohn's disease.
    Hocke M; Richter L; Bosseckert H; Eitner K
    Hepatogastroenterology; 1999; 46(28):2333-7. PubMed ID: 10521992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of platelet-activating factor in the pathogenesis of gastrointestinal disease.
    Travis SP; Jewell DP
    Prostaglandins Leukot Essent Fatty Acids; 1994 Mar; 50(3):105-13. PubMed ID: 8208748
    [No Abstract]   [Full Text] [Related]  

  • 6. Utility of a rapid fecal latex agglutination test detecting the neutrophil protein, lactoferrin, for diagnosing inflammatory causes of chronic diarrhea.
    Fine KD; Ogunji F; George J; Niehaus MD; Guerrant RL
    Am J Gastroenterol; 1998 Aug; 93(8):1300-5. PubMed ID: 9707055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of platelet-activating factor (PAF) in stools of newborn infants with hemorrhagic colitis].
    de Boissieu D; Badoual J; Dupont C; Chaussade S; Denizot Y; Benveniste J
    Arch Fr Pediatr; 1991; 48(7):515-6. PubMed ID: 1929756
    [No Abstract]   [Full Text] [Related]  

  • 8. Crohn's disease: emerging pathologic and bacterial spectrum.
    Freeman HJ
    Can J Surg; 1984 Sep; 27(5):431-3. PubMed ID: 6478319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
    Sartor RB
    Gastroenterol Clin North Am; 1995 Sep; 24(3):475-507. PubMed ID: 8809232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Etiology and pathogenesis of Crohn disease and ulcerative colitis].
    Knoflach P
    Wien Klin Wochenschr; 1986 Nov; 98(22):754-8. PubMed ID: 3811368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raised concentrations of platelet activating factor in colonic mucosa of Crohn's disease patients.
    Sobhani I; Hochlaf S; Denizot Y; Vissuzaine C; Rene E; Benveniste J; Lewin MM; Mignon M
    Gut; 1992 Sep; 33(9):1220-5. PubMed ID: 1427375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor--a possible mediator in the pathogenesis of ulcerative colitis.
    Rachmilewitz D; Karmeli F; Eliakim R
    Scand J Gastroenterol Suppl; 1990; 172():19-21. PubMed ID: 1972295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Etiology of chronic inflammatory bowel diseases].
    Purrmann J; Miller B; Strohmeyer G
    Z Gastroenterol; 1986 Jul; 24(7):357-63. PubMed ID: 3751201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neopterin concentration as an index of disease activity in Crohn's disease and ulcerative colitis.
    Husain N; Tokoro K; Popov JM; Naides SJ; Kwasny MJ; Buchman AL
    J Clin Gastroenterol; 2013 Mar; 47(3):246-51. PubMed ID: 23269308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cytokines and platelet-activating factor in inflammatory bowel disease. Implications for therapy.
    Nassif A; Longo WE; Mazuski JE; Vernava AM; Kaminski DL
    Dis Colon Rectum; 1996 Feb; 39(2):217-23. PubMed ID: 8620791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Paf-acether and digestive tract].
    Denizot Y; Chaussade S; Couturier D
    Gastroenterol Clin Biol; 1991; 15(11):817-22. PubMed ID: 1769471
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of ulcerative colitis and Crohn's disease with monoclonal antibody].
    Asakura H
    Nihon Rinsho; 2002 Mar; 60(3):531-8. PubMed ID: 11904969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of the role of platelet-activating factor in an animal model of inflammatory bowel disease.
    Wallace JL; Braquet P; Ibbotson GC; MacNaughton WK; Cirino G
    J Lipid Mediat; 1989; 1(1):13-23. PubMed ID: 2519884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory bowel disease. Considerations of etiology and pathogenesis.
    Kirsner JB
    Am J Gastroenterol; 1978 Mar; 69(3 Pt 1):253-71. PubMed ID: 665645
    [No Abstract]   [Full Text] [Related]  

  • 20. Concentrations of platelet activating factor in rectal mucosa in patients with ulcerative colitis.
    Almer S; Kald B; Franzén L; Ström M; Tagesson C
    Eur J Surg; 1996 May; 162(5):391-6. PubMed ID: 8781921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.